Correlation Between Neuropace and Telesis Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Telesis Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Telesis Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Telesis Bio, you can compare the effects of market volatilities on Neuropace and Telesis Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Telesis Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Telesis Bio.

Diversification Opportunities for Neuropace and Telesis Bio

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Neuropace and Telesis is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Telesis Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telesis Bio and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Telesis Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telesis Bio has no effect on the direction of Neuropace i.e., Neuropace and Telesis Bio go up and down completely randomly.

Pair Corralation between Neuropace and Telesis Bio

Given the investment horizon of 90 days Neuropace is expected to generate 4.89 times less return on investment than Telesis Bio. But when comparing it to its historical volatility, Neuropace is 6.07 times less risky than Telesis Bio. It trades about 0.13 of its potential returns per unit of risk. Telesis Bio is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  342.00  in Telesis Bio on September 3, 2024 and sell it today you would lose (44.00) from holding Telesis Bio or give up 12.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy37.5%
ValuesDaily Returns

Neuropace  vs.  Telesis Bio

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Telesis Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Telesis Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very weak forward indicators, Telesis Bio displayed solid returns over the last few months and may actually be approaching a breakup point.

Neuropace and Telesis Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Telesis Bio

The main advantage of trading using opposite Neuropace and Telesis Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Telesis Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telesis Bio will offset losses from the drop in Telesis Bio's long position.
The idea behind Neuropace and Telesis Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Correlations
Find global opportunities by holding instruments from different markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios